Episode 230: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
From Core EM - Emergency Medicine Podcast · 0:10:05
Show by Core EM
DRESS in the ED: Diagnosing this delayed drug reaction behind rash and shock & how to manage. Hosts: Nir Lavi-Romer, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/DRESS.mp3 Download Leave a Comment Tags: Allergy + Immunology, Critical Care, Dermatology, DRESS, Rash Podcast Video Show Notes Core EM Modular CME Course Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. Course Highlights: Credit: 12.5 AMA PRA Category 1 Credits™ Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics. Cost: Free for NYU Learners $250 for Non-NYU Learners Click Here to Register and Begin Module 1 DRESS vs SJS/TEN vs Anaphylaxis at a Glance DRESS SJS/TEN Anaphylaxis Onset after drug ~2–8 wks; hrs–days on re-exposure ~1–3 wks Min–hrs Skin Diffuse, infiltrated erythema; blisters rare Dusky lesions → blisters, sloughing Urticaria, flushing Nikolsky Neg Pos Neg Mucosa Mild, if any Severe, hemorrhagic Angioedema Big clues Facial edema, lymphadenopathy, eos, organ injury Epidermal detachment Wheeze, ↓BP, GI sx Response to epi None None Expected Background Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): drug exposure → rash + systemic involvement (liver, kidneys, lungs, heart, pancreas) Systemic dz is what makes pts critically ill → think ICU. Mortality up to ~10% in retrospective series; 1.7% in a prospective multinational registry (SEAIC 2020) Eosinophilia not universal → also called drug-induced hypersensitivity syndrome (DIHS) Rare, but can’t-miss Pathophysiology Type IV, T-cell–mediated delayed hypersensitivity; Th2 cytokines (IL-5) recruit eosinophils (SEAIC 2020) Not IgE-mediated → don’t expect an anaphylaxis-style response to epi Exact cause unclear. Two leading contributors: Genetics: HLA polymorphisms, e.g., HLA-A*31:01 w/ carbamazepine DRESS (CPIC 2018) Herpesvirus reactivation (HHV-6, HHV-7, EBV, CMV) in up to ~75%; cause vs consequence still unsettled The Culprit Drugs 200+ drugs implicated; a short list does most of the damage: Allopurinol, vancomycin, TMP-SMX & other sulfas Aromatic antiepileptic drugs (AEDs): phenytoin, phenobarbital, carbamazepine, lamotrigine Less common: NSAIDs, antiretrovirals, ACEi, CCBs, atypical antipsychotics Latency: classically 2–8 wks after starting the drug; re-exposure → hrs to days (SEAIC 2020) Med rec has to look back: SEAIC treats any drug started Clinical Presentation Rash: itchy morbilliform eruption → diffuse, confluent, infiltrated erythema, often >50% BSA; can be tender. Blisters & sloughing rare Facial edema: classic Lymphadenopathy (LAD), fever Mucosa: mild, ~half of pts, usually 1 site (mouth/pharynx) Organs: liver most common (~75%) & the leading cause of death; kidney (esp. allopurinol), lungs, heart (myocarditis), pancreas (SEAIC 2020) Sick end of the spectrum: shock, hypoxemia, AMS, multi-organ failure Diagnosis Clinical Dx Built on hx (new drug, wks back) + exam. Labs & biopsy support it; neither should hold up tx Sorting the Dangerous Rashes Anaphylaxis: min–hrs after exposure; urticaria, angioedema. No response to epi → reconsider Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): blisters, sloughing, severe hemorrhagic mucosal dz, Nikolsky pos Pemphigus vulgaris: flaccid bullae; Nikolsky & Asboe-Hansen pos Necrotizing soft tissue infection: pain out of proportion, crepitus Nikolsky: pressure on skin → epidermis shears/sloughs Asboe-Hansen: pressure on a bulla → fluid spreads laterally past its border Points to DRESS: delayed onset after a new drug, facial edema, LAD, no blistering/sloughing, mild mucosal dz Labs Gauge severity/end-organ damage, not the dx. Can be normal early → don’t use to exclude SEAIC admission panel: CBC w/ diff (eos, atypical lymphs), LFTs/INR, Cr + UA, lipase, CK, troponin (SEAIC 2020) Delphi: ECG for all; troponin/BNP only if cardiac involvement suspected (Delphi consensus 2024). Crashing pt → send the full panel up front Delphi grades severity on liver, kidney & blood derangement; any other organ involved = severe (Delphi consensus 2024) RegiSCAR Score Quantifies suspicion (MDCalc): 5 definite (SEAIC 2020) Early on, eos may not have appeared & a course ≥15 d can’t be confirmed (scores −1) → a low ED score doesn’t exclude Management Stop the Drug, Hold New Ones Stop every possible culprit Careful adding drugs to a sick pt; SEAIC specifically avoids empiric abx (esp. amoxicillin) & NSAIDs acutely (SEAIC 2020) Aromatic AED cross-reactivity 40–80% → avoid phenytoin, phenobarbital, lamotrigine, oxcarbazepine; benzos considered safe Resuscitate ABCs first, like any crashing pt Epi for any concern of anaphylaxis: unlikely to hurt, may help IVF titrated to dynamic measures & UOP; pressors for refractory shock Large BSA → burn-like insensible…
More episodes of Core EM - Emergency Medicine Podcast
More episodes
- Episode 229: Iron Poisoning
- Episode 228: Tickborne Illnesses
- Episode 227: Diarrhea
- Episode 217: Prehospital Blood Transfusion
- Episode 218: Sympathetic Crashing Acute Pulmonary Edema (SCAPE)
- Episode 219: Meningitis 2.0
- Episode 220: Post-ROSC Care
- Episode 221: High-Output Heart Failure
- Episode 222: Local Anesthetic Systemic Toxicity (LAST)
- Episode 223: Thyroid Storm
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.